MFGM
ABBV icon

Marshall Financial Group (Maryland)’s AbbVie ABBV Stock Holding History

Marshall Financial Group (Maryland)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Sell
1,034
-24
-2% -$5.16K 0.04% 275
2026
Q1 		$230K Sell
1,058
-26
-2% -$5.77K 0.04% 272
2025
Q4 		$248K Sell
1,084
-124
-10% -$28.2K 0.05% 256
2025
Q3 		$280K Sell
1,208
-101
-8% -$20.6K 0.05% 219
2025
Q2 		$246K Sell
1,309
-4,568
-78% -$849K 0.05% 229
2025
Q1 		$1.23M Sell
5,877
-135
-2% -$26.2K 0.27% 83
2024
Q4 		$1.07M Buy
6,012
+435
+8% +$80K 0.26% 97
2024
Q3 		$1.1M Buy
5,577
+194
+4% +$36.2K 0.26% 102
2024
Q2 		$923K Sell
5,383
-5,082
-49% -$842K 0.26% 104
2024
Q1 		$1.91M Buy
10,465
+558
+6% +$96.2K 0.55% 49
2023
Q4 		$1.54M Buy
+9,907
New +$1.44M 0.5% 55
2023
Q2 		– Sell
-1,456
Closed -$232K – 175
2023
Q1 		$232K Sell
1,456
-5,518
-79% -$844K 0.08% 158
2022
Q4 		$1.13M Buy
6,974
+744
+12% +$114K 0.44% 71
2022
Q3 		$836K Buy
6,230
+126
+2% +$18.1K 0.35% 89
2022
Q2 		$935K Buy
+6,104
New +$933K 0.37% 74

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Marshall Financial Group (Maryland)'s ABBV Position: Q2 2026 in Review

Marshall Financial Group (Maryland) reduced its AbbVie (ABBV) stake by 2.3% in Q2 2026, selling an estimated $5.16K and leaving 1,034 shares worth $260K. The position accounts for 0.04% of the portfolio, ranked #275.

Marshall Financial Group (Maryland) first reported a position in ABBV in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.91M in Q1 2024. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Marshall Financial Group (Maryland) held 1,034 shares of AbbVie worth $260K as of Q2 2026.
  • Marshall Financial Group (Maryland) sold 24 AbbVie shares in Q2 2026, an estimated $5.16K.
  • AbbVie made up 0.04% of Marshall Financial Group (Maryland)'s portfolio in Q2 2026, its #275 holding.
  • Marshall Financial Group (Maryland) first reported a position in AbbVie in Q2 2022 and has held it in 15 quarters since.
  • Marshall Financial Group (Maryland)'s AbbVie position peaked at $1.91M in Q1 2024.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q2 2026, filed 20 Jul 2026.